Largest real-world study finds tirzepatide (Mounjaro) up to
In the first comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data, Truveta Research...
Source: globenewswire.com
Cardiovascular Analytics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cardiovascular Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cardiovascular Analytics Today - Breaking & Trending Today
Mounjaro more effective than Ozempic for weight loss: Study
A new study of over 40,000 patients found that Eli Lilly's Mounjaro helped them lose weight more effectively than Novo Nordisk's Ozempic.
Source: beckershospitalreview.com
Experts' Perspectives: Top News in Cardiology for 2023
A group of 13 leading experts provides their perspectives on the top news in cardiovascular medicine from 2023, with responses ranging from novel approvals to new semaglutide data to gene therapy and more.
Source: hcplive.com
Data on Early Clinical Benefit for INPEFA® (Sotagliflozin) Will Be Among Five Lexicon-Sponsored ...
Cost-effectiveness data and analyses of financial impact among patients hospitalized for heart failure and treated with INPEFA included as important data selected for presentation
Source: eagletribune.com
How cardiology could change in 50 years, per 8 leaders
Explore the possibilities of cardiology in the next 50 years with 8 cardiology leaders.
Source: beckershospitalreview.com